Abstract

Simple SummaryCell-to-cell communication in the tumor microenvironment is a crucial process to orchestrate the different components of the tumoral infrastructure. Among the mechanisms of cellular interplay in cancer cells, tunneling nanotubes (TNTs) are dynamic connections that play an important role. The mechanism of the formation of TNTs among cells and the molecules involved in the process remain to be elucidated. In this study, we analyze several bladder cancer cell lines, representative of tumors at different stages and grades. We demonstrate that TNTs are formed only by mid or high-stage cell lines that show muscle-invasive properties and that they actively transport mitochondria and proteins. The formation of TNTs is triggered by stressful conditions and starts with the assembly of a specific multimolecular complex. In this study, we characterize some of the protein components of the TNTs complex, as they are potential novel molecular targets for future therapies aimed at counteracting tumor progression.RalGPS2 is a Ras-independent Guanine Nucleotide Exchange Factor for RalA GTPase that is involved in several cellular processes, including cytoskeletal organization. Previously, we demonstrated that RalGPS2 also plays a role in the formation of tunneling nanotubes (TNTs) in bladder cancer 5637 cells. In particular, TNTs are a novel mechanism of cell–cell communication in the tumor microenvironment, playing a central role in cancer progression and metastasis formation. However, the molecular mechanisms involved in TNTs formation still need to be fully elucidated. Here we demonstrate that mid and high-stage bladder cancer cell lines have functional TNTs, which can transfer mitochondria. Moreover, using confocal fluorescence time-lapse microscopy, we show in 5637 cells that TNTs mediate the trafficking of RalA protein and transmembrane MHC class III protein leukocyte-specific transcript 1 (LST1). Furthermore, we show that RalGPS2 is essential for nanotubes generation, and stress conditions boost its expression both in 5637 and HEK293 cell lines. Finally, we prove that RalGPS2 interacts with Akt and PDK1, in addition to LST1 and RalA, leading to the formation of a complex that promotes nanotubes formation. In conclusion, our findings suggest that in the tumor microenvironment, RalGPS2 orchestrates the assembly of multimolecular complexes that drive the formation of TNTs.

Highlights

  • IntroductionMost new cases of cancer are diagnosed when tumors are localized and confined within the organ affected, with a relatively high 5-year survival rate (~95%)

  • According to Global Cancer Statistics 2020 [1], bladder and kidney cancers together accounted for over 1 million new cases and about 400.000 new deaths worldwide in 2020.Most new cases of cancer are diagnosed when tumors are localized and confined within the organ affected, with a relatively high 5-year survival rate (~95%)

  • To characterize the bladder cancer microenvironment affected by tunneling nanotubes (TNTs), we analyzed a panel of six bladder cancer cell lines at different stages and grades, including RT4, RT112, 5637, HT1376, UMUC3 and J82 cell lines [48], which showed varying degrees of genetic complexity and different invasive properties

Read more

Summary

Introduction

Most new cases of cancer are diagnosed when tumors are localized and confined within the organ affected, with a relatively high 5-year survival rate (~95%). Many patients experience relapse within 5 years, some of them progressing to invasive disease with a significant drop in life expectancy (5-year relative survival rate of 13% and 6% for metastatic kidney and bladder cancer, respectively) [2,3,4]. Novel safe and effective therapeutic approaches for the treatment of bladder cancer are urgently needed. To this end, it is necessary to further investigate the molecular mechanisms underlying tumor progression, invasion and metastasis formation and identify new pharmacological targets

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call